H Sokol

Summary

Country: France

Publications

  1. ncbi request reprint Specificities of the fecal microbiota in inflammatory bowel disease
    Harry Sokol
    Unité d Ecologie et Physiologie du Système Digestif, INRA Research Center, Jouy en Josas, France
    Inflamm Bowel Dis 12:106-11. 2006
  2. pmc Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis
    Harry Sokol
    Gastroenterology and Nutrition Department, Hospital Saint Antoine 184, rue du Faubourg Saint Antoine, Cedex 12, Paris 75571, France
    World J Gastroenterol 14:3497-503. 2008
  3. pmc Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis
    Harry Sokol
    Gastroenterology and Nutrition Department, Saint Antoine Hospital, Pierre et Marie Curie Paris6 University, AP HP, 184 rue du Faubourg Saint Antoine, 75571, Paris, France
    World J Gastroenterol 16:583-7. 2010
  4. doi request reprint Low counts of Faecalibacterium prausnitzii in colitis microbiota
    H Sokol
    UEPSD, INRA, Jouy en Josas, France
    Inflamm Bowel Dis 15:1183-9. 2009
  5. doi request reprint The intestinal microbiota in inflammatory bowel diseases: time to connect with the host
    Harry Sokol
    Gastroenterology and Nutrition Department, Saint Antoine Hospital, Universite Pierre et Marie Curie, Paris VI, AP HP, Paris, France
    Curr Opin Gastroenterol 26:327-31. 2010
  6. doi request reprint Gastrointestinal involvement and manifestations in systemic mastocytosis
    Harry Sokol
    Department of Gastroenterology and Nutrition, Saint Antoine Hospital, Universite Paris VI, Faculte de Medecine, Assistance Publique Hopitaux de Paris, Paris, France
    Inflamm Bowel Dis 16:1247-53. 2010
  7. pmc The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
    D Mariat
    INRA, U910, Unité d Ecologie et du Système Digestif, Domaine de Vilvert, 78350 Jouy en Josas, France
    BMC Microbiol 9:123. 2009
  8. doi request reprint Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    P Marteau
    AP HP, Hopital Lariboisiere, Medicosurgical Department of Digestive Diseases, Laboratoire de Biologie EA 3199, CNAM and University Diderot Paris 7, Paris, France
    Gastroenterol Clin Biol 33:S228-34. 2009
  9. doi request reprint Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine
    P Seksik
    Département de Gastroentérologie and Nutrition, Hopital Saint Antoine, Universite Pierre et Marie Curie Paris VI, AP HP, Paris, France
    Aliment Pharmacol Ther 29:1106-13. 2009
  10. ncbi request reprint Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
    P Seksik
    Département d Hépato Gastroentérologie, Hopital Saint Antoine, AP HP, Paris, France
    Aliment Pharmacol Ther 24:11-8. 2006

Detail Information

Publications17

  1. ncbi request reprint Specificities of the fecal microbiota in inflammatory bowel disease
    Harry Sokol
    Unité d Ecologie et Physiologie du Système Digestif, INRA Research Center, Jouy en Josas, France
    Inflamm Bowel Dis 12:106-11. 2006
    ..The aim of this study was to compare the bacterial composition of the dominant fecal microbiota in patients with Crohn's disease (CD), ulcerative colitis (UC), infectious colitis (IC), and in healthy subjects (HS)...
  2. pmc Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis
    Harry Sokol
    Gastroenterology and Nutrition Department, Hospital Saint Antoine 184, rue du Faubourg Saint Antoine, Cedex 12, Paris 75571, France
    World J Gastroenterol 14:3497-503. 2008
    ..To investigate the phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD)...
  3. pmc Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis
    Harry Sokol
    Gastroenterology and Nutrition Department, Saint Antoine Hospital, Pierre et Marie Curie Paris6 University, AP HP, 184 rue du Faubourg Saint Antoine, 75571, Paris, France
    World J Gastroenterol 16:583-7. 2010
    ..To evaluate whether crypt abscesses from inflammatory bowel disease (IBD) patients contain bacteria and to establish their nature...
  4. doi request reprint Low counts of Faecalibacterium prausnitzii in colitis microbiota
    H Sokol
    UEPSD, INRA, Jouy en Josas, France
    Inflamm Bowel Dis 15:1183-9. 2009
    ..The aim was to compare the fecal microbiota composition of patients with colitis to that of healthy subjects (HS)...
  5. doi request reprint The intestinal microbiota in inflammatory bowel diseases: time to connect with the host
    Harry Sokol
    Gastroenterology and Nutrition Department, Saint Antoine Hospital, Universite Pierre et Marie Curie, Paris VI, AP HP, Paris, France
    Curr Opin Gastroenterol 26:327-31. 2010
    ..The aim of this review is to report recent findings regarding the role of the gut microbiota in inflammatory bowel disease pathogenesis...
  6. doi request reprint Gastrointestinal involvement and manifestations in systemic mastocytosis
    Harry Sokol
    Department of Gastroenterology and Nutrition, Saint Antoine Hospital, Universite Paris VI, Faculte de Medecine, Assistance Publique Hopitaux de Paris, Paris, France
    Inflamm Bowel Dis 16:1247-53. 2010
    ..Diagnosis of mastocytosis GI manifestations should be evoked in the case of unexplained severe GI disorders...
  7. pmc The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
    D Mariat
    INRA, U910, Unité d Ecologie et du Système Digestif, Domaine de Vilvert, 78350 Jouy en Josas, France
    BMC Microbiol 9:123. 2009
    ..Applying current molecular methods is necessary to surmount the limitations of classical culturing techniques in order to obtain an accurate description of the microbiota composition...
  8. doi request reprint Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    P Marteau
    AP HP, Hopital Lariboisiere, Medicosurgical Department of Digestive Diseases, Laboratoire de Biologie EA 3199, CNAM and University Diderot Paris 7, Paris, France
    Gastroenterol Clin Biol 33:S228-34. 2009
    ..We also discuss the mechanisms of action, the use of microbial agents as pharmacological vectors, the development of genetically modified probiotics (including a clinical pilot trial in patients with Crohn's disease), and safety issues...
  9. doi request reprint Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine
    P Seksik
    Département de Gastroentérologie and Nutrition, Hopital Saint Antoine, Universite Pierre et Marie Curie Paris VI, AP HP, Paris, France
    Aliment Pharmacol Ther 29:1106-13. 2009
    ..There are few data on the incidence of benign infections (upper respiratory tract infections, herpes lesions and viral warts) during exposure to azathioprine...
  10. ncbi request reprint Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
    P Seksik
    Département d Hépato Gastroentérologie, Hopital Saint Antoine, AP HP, Paris, France
    Aliment Pharmacol Ther 24:11-8. 2006
    ..Studies searching for a generalized or localized dysbiosis in IBD are discussed, as well as those trying to identify bacterial molecules and receptors, which may be implicated in triggering the inflammatory process...
  11. doi request reprint Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease
    H Sokol
    AP HP, Saint Antoine Hospital, Gastroenterology and Nutrition Department, Paris, France
    Gut 58:1218-25. 2009
    ..The aim of the present study was to assess the predictive value of plexitis for early clinical CD recurrence...
  12. pmc Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis
    H Sokol
    INRA, UEPSD, CR de Jouy en Josas, 78352 Jouy en Josas, France
    J Clin Microbiol 44:3172-7. 2006
    ..E. coli is more represented in the active microbiota of UC patients. The possible pathophysiological role of this difference remains to be determined...
  13. doi request reprint Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome
    H Duboc
    Hepato Gastro Enterology Department, Louis Mourier Hospital, University Paris VII, AP HP, Colombes, France
    Neurogastroenterol Motil 24:513-20, e246-7. 2012
    ..We compared fecal BA profiles and microbiota in healthy subjects (HS) and patients with diarrhea-predominant IBS (IBS-D), and we searched for an association with symptoms...
  14. doi request reprint Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle
    H Sokol
    Department of Gastroenterology and Nutrition, AP HP, Hôpital Saint Antoine and UPMC University Paris 06, Paris, France
    Gut 58:1427-36. 2009
    ....
  15. doi request reprint Unilateral carotid granulomatous arteritis and Crohn's disease
    C Gobron
    Service de Neurologie, Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, 2, rue Ambroise Pare, 75010 Paris, France
    Rev Neurol (Paris) 166:542-6. 2010
    ..Biopsies of the temporal and carotid arteries showed large-vessel granulomatous arteritis, with features of both giant cell and Takayasu's arteritis...
  16. doi request reprint Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Philippe Seksik
    AP HP, Hopital Saint Antoine, Gastroenterology and Nutrition Department, University Pierre et Marie Curie, Paris, France
    Mol Nutr Food Res 52:906-12. 2008
    ..Despite an ecological (hopefully nutritional) treatment of IBD is promising, many questions remain unanswered and further clinical and fundamental studies are needed...
  17. doi request reprint Analysis of bacterial bowel communities of IBD patients: what has it revealed?
    Harry Sokol
    Gastroenterology and Nutrition Unit, Saint Antoine Hospital, APHP, Paris, France
    Inflamm Bowel Dis 14:858-67. 2008
    ..Confounding factors need to be eliminated from future studies by using better-defined patient populations of newly diagnosed and untreated individuals and by improved sampling procedures...